Dr. Chaudhri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
126 East Lincoln Ave
Merck Research Laboratories
Rahway, NJ 07065
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Gastroenterology, 1992 - 1994
- Johns Hopkins UniversityResidency, Internal Medicine, 1989 - 1991
- MCP-Hahnemann College of MedicineClass of 1989
Certifications & Licensure
- NJ State Medical License 1995 - 2025
- NY State Medical License 1991 - 1996
Publications & Presentations
PubMed
- 519 citationsEfficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infe...Paul Y. Kwo, Eric Lawitz, Jonathan McCone, Eugene R. Schiff, John M. Vierling
Lancet. 2010-08-28 - 37 citationsA phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease.Manuel Romero-Gómez, Eric Lawitz, R Ravi Shankar, Eirum Chaudhri, Jie Liu
Journal of Hepatology. 2023-10-01 - 17 citationsResistance-associated amino acid variants associated with boceprevir plus pegylated interferon-α2b and ribavirin in patients with chronic hepatitis C in the SPRINT-1 t...Robert A. Ogert, John A. Howe, John M. Vierling, Paul Y. Kwo, Eric Lawitz
Antiviral Therapy. 2013-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: